MacroGenics
MGNX
#9393
Rank
S$0.11 B
Marketcap
S$1.78
Share price
-0.72%
Change (1 day)
-60.87%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.26 Billion

According to MacroGenics's latest financial reports the company's total liabilities are S$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.19 B2.77%
2023-12-31S$0.19 B3.75%
2022-12-31S$0.18 B43.58%
2021-12-31S$0.12 B17.94%
2020-12-31S$0.10 B-0.69%
2019-12-31S$0.11 B-9.48%
2018-12-31S$0.12 B22.13%
2017-12-31S$99.83 M62.26%
2016-12-31S$61.52 M-5.3%
2015-12-31S$64.97 M-6.52%
2014-12-31S$69.5 M17.05%
2013-12-31S$59.38 M-21.66%
2012-12-31S$75.8 M-26.99%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
S$0.31 B 19.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 56,650.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.61 B 38,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$48.04 B 18,096.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.34 B 39,417.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.03 B 44,601.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.45 B 38,321.79%๐Ÿ‡บ๐Ÿ‡ธ USA